BFlow S.L. will take part in the Swiss Biotech Day, one of Europe’s key biotech events. It brings together companies, researchers, investors, and industry leaders from around the world. The goal is to share knowledge, build partnerships, and explore new opportunities.

During the event, BFlow will be represented by its General Manager, Enrique Sánchez and Chief Scientific Officer, Andrés Da Silva. They will present the company’s organ-on-a-chip technology and highlight its potential to improve the way biomedical research is conducted, enabling more predictive and human-relevant models for applications such as drug development.

BFlow’s participation reflects its commitment to strengthening its international presence and engaging with key players in the global biotech ecosystem. The company aims to explore new partnership opportunities, share its expertise and contribute to ongoing discussions on the future of microphysiological systems.

If you are attending the Swiss Biotech Day and would like to learn more about BFlow or discuss potential collaborations, we welcome the opportunity to connect.